A review of randomized controlled trials suggests patients with epilepsy refractory to medical management may benefit from vagal nerve stimulation. A new review suggests that vagal nerve stimulation ...

Although the condition is rare and cases are limited, researchers were able to generally conclude vagal nerve stimulation (VNS) serves as a well-tolerated intervention. In a recent perspective piece, ...

ATLANTA -- Are neurostimulators implanted within the brain a better approach in epilepsy than less-invasive vagus nerve stimulation (VNS)? That depends, a researcher said. Real-world data from two ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) Annual Meeting ...

London-based medical device manufacturer LivaNova has announced FDA approval of its most recent Vagus Nerve Stimulation Therapy (VNS Therapy) System, which will be the smallest and lightest responsive ...

A new study has examined a population of pediatric patients with drug-resistant epilepsy. For these patients, the study found that the patients who received vagus nerve stimulation (VNS), when used ...

Please provide your email address to receive an email when new articles are posted on . Researchers analyzed records of more than 600 vagus nerve stimulation surgeries. Mean surgery duration for those ...

The vagus nerve stimulator (VNS) is a pacemaker-like device implanted in the chest that delivers intermittent electrical signals to the brain via an electrode wrapped around the left vagus nerve. The ...

University of Liverpool researchers have begun work on a major £2.7 million National Institute for Health and Care Research (NIHR)-funded trial investigating the long-term effectiveness of vagus nerve ...

(Columbia) Oct. 2, 2003 - Cameron Rambo is 8-years-old, and his grandma loves giving him kisses. What Georgia Dove doesn't love are the effects of Cameron's epilepsy, "Cameron was two when he started ...

Epilepsy is one of the most common neurological diseases, affecting around 50 million people worldwide, and carries a debilitating burden for the patient. It is characterized by recurrent seizures ...